FDA Announces Review of Opioid Prescribing Regulations and F

The head of the Food and Drug Administration (FDA), Dr. Robert Califf, announced on August 30, 2022 that, in addition to an extensive review of opioid regulations, the agency is...

Related Keywords

United States , Americans , Robert Califf , Us Department Of Health , Human Services , Drug Enforcement Administration , Health Care Viewpoints , National Drug Control Strategy , Drug Administration , Development Of Evidence , International Mail Facilities , Commissioner Califf , Overdose Prevention Strategy , President Biden , National Drug Control , Component One , Supporting Primary , Opioid Analgesic Risk Evaluation , Mitigation Strategy , Substance Use Disorder Prevention , Promotes Opioid Recovery , Communities Act , Opioid Analgesic , Component Two , Encouraging Harm , Component Three , Advancing Development , Component Four , Counterfeit Drugs Presenting Overdose , Express Couriers ,